Sabra Healthcare REIT’s (NASDAQ:SBRA) Hold Rating Reiterated at Jefferies Group LLC
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)‘s stock had its “hold” rating reissued by equities researchers at Jefferies Group LLC in a note issued to investors on Sunday. They currently have a $25.00 price objective on the real estate investment trust’s stock, down from their prior price objective of $28.00. Jefferies Group LLC’s price objective points to a potential upside of 7.94% from the stock’s current price.
A number of other brokerages have also recently commented on SBRA. BidaskClub raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Tuesday, June 20th. Mizuho reaffirmed a “neutral” rating on shares of Sabra Healthcare REIT in a report on Wednesday, June 28th. Zacks Investment Research lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Thursday, June 8th. Canaccord Genuity reiterated a “hold” rating and issued a $26.00 price target on shares of Sabra Healthcare REIT in a research report on Tuesday, May 9th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $30.00 price target on shares of Sabra Healthcare REIT in a research report on Monday, May 8th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company. Sabra Healthcare REIT currently has an average rating of “Hold” and an average target price of $27.29.
Sabra Healthcare REIT (NASDAQ SBRA) opened at 23.16 on Friday. Sabra Healthcare REIT has a 12-month low of $19.30 and a 12-month high of $29.10.
Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, May 8th. The real estate investment trust reported $0.25 EPS for the quarter, missing the Zacks’ consensus estimate of $0.58 by $0.33. Sabra Healthcare REIT had a net margin of 40.22% and a return on equity of 10.35%. The business had revenue of $62.65 million for the quarter, compared to analysts’ expectations of $63.47 million. During the same period in the prior year, the company posted $0.54 earnings per share. The firm’s quarterly revenue was up .1% on a year-over-year basis. On average, analysts expect that Sabra Healthcare REIT will post $1.20 EPS for the current year.
Several institutional investors have recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Sabra Healthcare REIT by 14.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust’s stock worth $106,000 after buying an additional 471 shares during the last quarter. Bank of Montreal Can raised its position in shares of Sabra Healthcare REIT by 44.1% in the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock worth $109,000 after buying an additional 1,191 shares in the last quarter. Russell Investments Group Ltd. bought a new position in shares of Sabra Healthcare REIT during the fourth quarter worth $120,000. Ameritas Investment Partners Inc. bought a new position in shares of Sabra Healthcare REIT during the first quarter worth $156,000. Finally, Stratos Wealth Partners LTD. bought a new position in shares of Sabra Healthcare REIT during the first quarter worth $207,000. Institutional investors and hedge funds own 99.47% of the company’s stock.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.